Should You Buy Oramed Pharmaceuticals, Inc. (ORMP) Stock on Friday?

Overall market sentiment has been down on Oramed Pharmaceuticals, Inc. (ORMP) stock lately. ORMP receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Oramed Pharmaceuticals, Inc. has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on ORMP!

See Full ORMP Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With ORMP Stock Today?

Oramed Pharmaceuticals, Inc. (ORMP) stock has fallen -1.52% while the S&P 500 has gained 0.21% as of 9:59 AM on Friday, Sep 22. ORMP is down -$0.04 from the previous closing price of $2.63 on volume of 58,106 shares. Over the past year the S&P 500 has gained 14.49% while ORMP is down -64.42%. ORMP lost -$0.51 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for Oramed Pharmaceuticals, Inc. click here.

More About Oramed Pharmaceuticals, Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The ORMD-0801 is a proprietary product which is an orally ingestible insulin capsule for the treatment of diabetes. Its other product includes Oral Glucagon-like peptide-1 which is an incretin hormone, a type of gastrointestinal hormone that stimulates the secretion of insulin from the pancreas. Click Here to get the full Stock Report for Oramed Pharmaceuticals, Inc. stock.